Thymosin Beta-4

Thymosin Beta-4 (Tβ4) is a naturally occurring 43-amino acid peptide that plays a crucial role in tissue repair, wound healing, and cellular regeneration. It promotes angiogenesis, reduces inflammation, and supports the migration and differentiation of various cell types involved in healing processes.

• Wound Healing Acceleration
• Post-Surgical Recovery
• Soft Tissue Injury Repair

Systemic regenerative effects, proven clinical efficacy, optimal bioavailability for tissue repair

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects

Research protocols from published literature — not dosing recommendations.

• TB-500 — Synergistic: TB-500 is the bioactive fragment of Thymosin β4. Combined use provides full-length peptide benefits plus concentrated bioactive effects for enhanced tissue repair.
• BPC-157 — Synergistic: Complementary healing mechanisms - Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection and systemic healing.
• Growth Hormone — Compatible: No direct interactions reported. Both promote tissue repair through different pathways and can be used together safely.
• IGF-1 — Compatible: Complementary growth factor effects without direct interaction. Both support tissue regeneration through distinct mechanisms.
• Corticosteroids — Use Caution: Steroids may reduce Thymosin β4 effectiveness by inhibiting inflammatory responses necessary for optimal healing.
• Anticoagulants — Monitor Combination: Tβ4 promotes angiogenesis which may affect bleeding risk. Monitor coagulation parameters when used with warfarin or similar agents.
• NSAIDs — Requires Timing: High-dose NSAIDs may interfere with inflammatory processes necessary for Tβ4-mediated healing. Consider timing or reduced NSAID dosing.
• Chemotherapy — Avoid Combination: Theoretical concern about promoting angiogenesis in cancer patients. Avoid use during active chemotherapy treatment.

Supplies:

• Thymosin β4 lyophilized powder (sterile vial)
• Bacteriostatic water for injection (BWFI)
• Sterile syringes and needles
• Alcohol swabs and sterile gauze

1. 1Allow lyophilized powder to reach room temperature before reconstitution
2. 2Add bacteriostatic water slowly to the vial wall, avoiding direct contact with powder
3. 3Gently swirl (do not shake vigorously) until completely dissolved
4. 4Inspect solution for clarity - should be clear and colorless
5. 5Store reconstituted solution at 2-8°C and use within 14 days
6. 6For injection, use proper aseptic technique and rotate injection sites

Week 1-2: Initial tissue response, possible mild injection site reactions. Week 2-4: Accelerated healing becomes apparent, reduced inflammation. Week 4-8: Significant tissue regeneration and functional improvement. Week 8-12: Sustained benefits and near-complete healing in responsive conditions.

Monitor injection sites for local reactions or inflammation. Use sterile technique to prevent infection at injection sites. Start with lower doses to assess individual tolerance. Discontinue if signs of allergic reaction or unusual side effects.

Monitor injection sites for local reactions or inflammation. Use sterile technique to prevent infection at injection sites. Start with lower doses to assess individual tolerance. Discontinue if signs of allergic reaction or unusual side effects.

Thymosin Beta-4 should be stored at Lyophilized: room temperature; Reconstituted: 2-8°C for up to 14 days.